Amedisys Inc's Chief Human Resources Officer just picked up 5,521 shares

Sharon Brunecz, Amedisys Inc's Chief Human Resources Officer, recently acquired 5,521 shares of the company. The buys took place at $0.00 per share, on February 20, 2019. Brunecz now owns 13,939 shares of the company. Brunecz operates out of Baton Rouge, LA. Some additional info was provided as follows:

The Issuer awarded the Reporting Person 1,328 time-based Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2020, 2021, 2022 and 2023, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The information in this report is based on a plan statement dated as of December 31, 2018. The RSUs are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2018 through 2021, respectively, and (ii) additional time-based vesting conditions (2018 Tranche: one-third on each of July 27, 2019, 2020 and 2021; 2019 Tranche: one-third on each of July 27, 2020, 2021 and 2022; 2020 Tranche: one-third on each of July 27, 2021, 2022 and 2023; and 2021 Tranche: one-third on each of July 27, 2022, 2023 and 2024), assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2018 were met. The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2020, 2021, 2022 and 2023, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2019, with additional time-based vesting in equal 25% installments on each of February 20, 2020, 2021, 2022 and 2023, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 50%-200% of the amount reported depending on the level of performance achieved.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Amedisys Inc makes a similar move, sign up!

Other recent filings from the company include the following:

Amedisys: Compassionate Care Hospice Group, Inc AND SUBSIDIARIES AND AFFILIATES - April 17, 2019
Amedisys: Vice President Of Marketing & Communications - April 1, 2019

Auto Refresh

Feedback